Skip to main content
OpenTrials
Completed

NCT Number: NCT06968117

Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

France

Gonesse, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • During pregnancy follow-up consultations,
  • Following their visit to the Gynecology-Obstetrics emergency department, regardless of the reason,
  • Hospitalized in the diabetology department or in the high-risk pregnancy (HRP) or postpartum care department.

Exclusion criteria

  • The patient is over 18 years old

Treatment and study plan

Primary outcomes

  1. The rate of vaccine hesitancy among pregnant women, assessed through a standardized questionnaire.

    Time frame: January 2021-April 2023

Sponsors and collaborators

Lead sponsor

Centre Hospitalier de Gonesse

Other

Registry information

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
May 13, 2025
Registry last updated
May 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.